Bullock R

References (31)

Title : Statins for the treatment of dementia - McGuinness_2014_Cochrane.Database.Syst.Rev_7_CD007514
Author(s) : McGuinness B , Craig D , Bullock R , Malouf R , Passmore P
Ref : Cochrane Database Syst Rev , 7 :CD007514 , 2014
Abstract :
PubMedSearch : McGuinness_2014_Cochrane.Database.Syst.Rev_7_CD007514
PubMedID: 25004278

Title : Cochrane review on 'Statins for the treatment of dementia' - McGuinness_2013_Int.J.Geriatr.Psychiatry_28_119
Author(s) : McGuinness B , O'Hare J , Craig D , Bullock R , Malouf R , Passmore P
Ref : Int J Geriatr Psychiatry , 28 :119 , 2013
Abstract :
PubMedSearch : McGuinness_2013_Int.J.Geriatr.Psychiatry_28_119
PubMedID: 22473869

Title : Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease - Emre_2010_CNS.Neurosci.Ther_16_246
Author(s) : Emre M , Bernabei R , Blesa R , Bullock R , Cunha L , Daniels H , Dziadulewicz E , Forstl H , Frolich L , Gabryelewicz T , Levin O , Lindesay J , Martinez-Lage P , Monsch A , Tsolaki M , van Laar T
Ref : CNS Neurosci Ther , 16 :246 , 2010
Abstract :
PubMedSearch : Emre_2010_CNS.Neurosci.Ther_16_246
PubMedID: 20370805

Title : Statins for the treatment of dementia - McGuinness_2010_Cochrane.Database.Syst.Rev_8_CD007514
Author(s) : McGuinness B , O'Hare J , Craig D , Bullock R , Malouf R , Passmore P
Ref : Cochrane Database Syst Rev , 8 :CD007514 , 2010
Abstract :
PubMedSearch : McGuinness_2010_Cochrane.Database.Syst.Rev_8_CD007514
PubMedID: 20687089

Title : Cholinesterase inhibition: is there evidence for disease-modifying effects? - Shanks_2009_Curr.Med.Res.Opin_25_2439
Author(s) : Shanks M , Kivipelto M , Bullock R , Lane R
Ref : Curr Med Res Opin , 25 :2439 , 2009
Abstract :
PubMedSearch : Shanks_2009_Curr.Med.Res.Opin_25_2439
PubMedID: 19678754

Title : Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial) - Ballard_2009_Am.J.Geriatr.Psychiatry_17_726
Author(s) : Ballard C , Brown R , Fossey J , Douglas S , Bradley P , Hancock J , James IA , Juszczak E , Bentham P , Burns A , Lindesay J , Jacoby R , O'Brien J , Bullock R , Johnson T , Holmes C , Howard R
Ref : American Journal of Geriatry & Psychiatry , 17 :726 , 2009
Abstract :
PubMedSearch : Ballard_2009_Am.J.Geriatr.Psychiatry_17_726
PubMedID: 19700946

Title : Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II - Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
Author(s) : Aalten P , Verhey FR , Boziki M , Brugnolo A , Bullock R , Byrne EJ , Camus V , Caputo M , Collins D , De Deyn PP , Elina K , Frisoni G , Holmes C , Hurt C , Marriott A , Mecocci P , Nobili F , Ousset PJ , Reynish E , Salmon E , Tsolaki M , Vellas B , Robert PH
Ref : Dementia & Geriatric Cognitive Disorders , 25 :1 , 2008
Abstract :
PubMedSearch : Aalten_2008_Dement.Geriatr.Cogn.Disord_25_1
PubMedID: 18025783

Title : Strategies to improve tolerability of rivastigmine: a case series - Venkatesh_2007_Curr.Med.Res.Opin_23_93
Author(s) : Venkatesh K , Bullock R , Akbas A
Ref : Curr Med Res Opin , 23 :93 , 2007
Abstract :
PubMedSearch : Venkatesh_2007_Curr.Med.Res.Opin_23_93
PubMedID: 17257470

Title : Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase - Bullock_2007_Curr.Alzheimer.Res_4_277
Author(s) : Bullock R , Lane R
Ref : Curr Alzheimer Res , 4 :277 , 2007
Abstract :
PubMedSearch : Bullock_2007_Curr.Alzheimer.Res_4_277
PubMedID: 17627485

Title : Donepezil for the treatment of agitation in Alzheimer's disease - Howard_2007_N.Engl.J.Med_357_1382
Author(s) : Howard RJ , Juszczak E , Ballard CG , Bentham P , Brown RG , Bullock R , Burns AS , Holmes C , Jacoby R , Johnson T , Knapp M , Lindesay J , O'Brien JT , Wilcock G , Katona C , Jones RW , DeCesare J , Rodger M
Ref : N Engl J Med , 357 :1382 , 2007
Abstract :
PubMedSearch : Howard_2007_N.Engl.J.Med_357_1382
PubMedID: 17914039

Title : Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology - Burns_2006_J.Psychopharmacol_20_732
Author(s) : Burns A , O'Brien J , Auriacombe S , Ballard C , Broich K , Bullock R , Feldman H , Ford G , Knapp M , McCaddon A , Iliffe S , Jacova C , Jones R , Lennon S , McKeith I , Orgogozo JM , Purandare N , Richardson M , Ritchie C , Thomas A , Warner J , Wilcock G , Wilkinson D
Ref : J Psychopharmacol , 20 :732 , 2006
Abstract :
PubMedSearch : Burns_2006_J.Psychopharmacol_20_732
PubMedID: 17060346

Title : Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease - Bullock_2006_Curr.Med.Res.Opin_22_483
Author(s) : Bullock R , Bergman H , Touchon J , Gambina G , He Y , Nagel J , Lane R
Ref : Curr Med Res Opin , 22 :483 , 2006
Abstract :
PubMedSearch : Bullock_2006_Curr.Med.Res.Opin_22_483
PubMedID: 16574032

Title : Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date - Bullock_2006_Alzheimer.Dis.Assoc.Disord_20_23
Author(s) : Bullock R
Ref : Alzheimer Disease & Associated Disorders , 20 :23 , 2006
Abstract :
PubMedSearch : Bullock_2006_Alzheimer.Dis.Assoc.Disord_20_23
PubMedID: 16493232

Title : Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease - Blesa_2006_Pharmacogenet.Genomics_16_771
Author(s) : Blesa R , Bullock R , He Y , Bergman H , Gambina G , Meyer J , Rapatz G , Nagel J , Lane R
Ref : Pharmacogenet Genomics , 16 :771 , 2006
Abstract :
PubMedSearch : Blesa_2006_Pharmacogenet.Genomics_16_771
PubMedID: 17047484

Title : Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings - Bullock_2005_Curr.Med.Res.Opin_21_1
Author(s) : Bullock R
Ref : Curr Med Res Opin , 21 :1 , 2005
Abstract :
PubMedSearch : Bullock_2005_Curr.Med.Res.Opin_21_1
PubMedID: 15881470

Title : Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years - Bullock_2005_Int.J.Clin.Pract_59_817
Author(s) : Bullock R , Dengiz A
Ref : Int J Clin Pract , 59 :817 , 2005
Abstract :
PubMedSearch : Bullock_2005_Int.J.Clin.Pract_59_817
PubMedID: 15963209

Title : Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period - Bullock_2005_Curr.Med.Res.Opin_21_1317
Author(s) : Bullock R , Touchon J , Bergman H , Gambina G , He Y , Rapatz G , Nagel J , Lane R
Ref : Curr Med Res Opin , 21 :1317 , 2005
Abstract :
PubMedSearch : Bullock_2005_Curr.Med.Res.Opin_21_1317
PubMedID: 16083542

Title : Galantamine: use in Alzheimer's disease and related disorders - Bullock_2004_Expert.Rev.Neurother_4_153
Author(s) : Bullock R
Ref : Expert Rev Neurother , 4 :153 , 2004
Abstract :
PubMedSearch : Bullock_2004_Expert.Rev.Neurother_4_153
PubMedID: 15853556

Title : The needs of the caregiver in the long-term treatment of Alzheimer disease - Bullock_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S17
Author(s) : Bullock R
Ref : Alzheimer Disease & Associated Disorders , 18 Suppl 1 :S17 , 2004
Abstract :
PubMedSearch : Bullock_2004_Alzheimer.Dis.Assoc.Disord_18 Suppl 1_S17
PubMedID: 15249844

Title : Cholinesterase inhibitors and vascular dementia: another string to their bow? - Bullock_2004_CNS.Drugs_18_79
Author(s) : Bullock R
Ref : CNS Drugs , 18 :79 , 2004
Abstract :
PubMedSearch : Bullock_2004_CNS.Drugs_18_79
PubMedID: 14728055

Title : Future directions in the treatment of Alzheimer's disease - Bullock_2004_Expert.Opin.Investig.Drugs_13_303
Author(s) : Bullock R
Ref : Expert Opin Investig Drugs , 13 :303 , 2004
Abstract :
PubMedSearch : Bullock_2004_Expert.Opin.Investig.Drugs_13_303
PubMedID: 15102582

Title : Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors - Gauthier_2003_Curr.Med.Res.Opin_19_707
Author(s) : Gauthier S , Emre M , Farlow MR , Bullock R , Grossberg GT , Potkin SG
Ref : Curr Med Res Opin , 19 :707 , 2003
Abstract :
PubMedSearch : Gauthier_2003_Curr.Med.Res.Opin_19_707
PubMedID: 14687441

Title : Realistic expectations: the management of severe Alzheimer disease - Bullock_2003_Alzheimer.Dis.Assoc.Disord_17 Suppl 3_S80
Author(s) : Bullock R , Hammond G
Ref : Alzheimer Disease & Associated Disorders , 17 Suppl 3 :S80 , 2003
Abstract :
PubMedSearch : Bullock_2003_Alzheimer.Dis.Assoc.Disord_17 Suppl 3_S80
PubMedID: 14512821

Title : Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK - Ward_2003_Int.J.Geriatr.Psychiatry_18_740
Author(s) : Ward A , Caro JJ , Getsios D , Ishak K , O'Brien J , Bullock R
Ref : Int J Geriatr Psychiatry , 18 :740 , 2003
Abstract :
PubMedSearch : Ward_2003_Int.J.Geriatr.Psychiatry_18_740
PubMedID: 12891643

Title : An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia - Erkinjuntti_2003_Clin.Ther_25_1765
Author(s) : Erkinjuntti T , Kurz A , Small GW , Bullock R , Lilienfeld S , Damaraju CV
Ref : Clin Ther , 25 :1765 , 2003
Abstract :
PubMedSearch : Erkinjuntti_2003_Clin.Ther_25_1765
PubMedID: 12860497

Title : New drugs for Alzheimer's disease and other dementias - Bullock_2002_Br.J.Psychiatry_180_135
Author(s) : Bullock R
Ref : British Journal of Psychiatry , 180 :135 , 2002
Abstract :
PubMedSearch : Bullock_2002_Br.J.Psychiatry_180_135
PubMedID: 11823323

Title : The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis - Bullock_2002_Int.J.Clin.Pract_56_206
Author(s) : Bullock R
Ref : Int J Clin Pract , 56 :206 , 2002
Abstract :
PubMedSearch : Bullock_2002_Int.J.Clin.Pract_56_206
PubMedID: 12018828

Title : Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it? -
Author(s) : Bullock R , Connolly C
Ref : Int J Geriatr Psychiatry , 17 :288 , 2002
PubMedID: 11921158

Title : A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease - Wilkinson_2002_Int.J.Clin.Pract_56_441
Author(s) : Wilkinson DG , Passmore AP , Bullock R , Hopker SW , Smith R , Potocnik FC , Maud CM , Engelbrecht I , Hock C , Ieni JR , Bahra RS
Ref : Int J Clin Pract , 56 :441 , 2002
Abstract :
PubMedSearch : Wilkinson_2002_Int.J.Clin.Pract_56_441
PubMedID: 12166542

Title : Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial - Erkinjuntti_2002_Lancet_359_1283
Author(s) : Erkinjuntti T , Kurz A , Gauthier S , Bullock R , Lilienfeld S , Damaraju CV
Ref : Lancet , 359 :1283 , 2002
Abstract :
PubMedSearch : Erkinjuntti_2002_Lancet_359_1283
PubMedID: 11965273

Title : Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series - Bullock_2002_Curr.Med.Res.Opin_18_258
Author(s) : Bullock R , Cameron A
Ref : Curr Med Res Opin , 18 :258 , 2002
Abstract :
PubMedSearch : Bullock_2002_Curr.Med.Res.Opin_18_258
PubMedID: 12240787